Letter to the editorWendy T. Parker, Stuart R. Phillis, David T. O. Yeung, Timothy P. Hughes, Hamish S. Scott, and Susan Branfor
Copyright © 2004 by American Society of HematologyMutations within the BCR-ABL kinase domain in imat...
In imatinib-treated chronic myeloid leuke-mia (CML), secondary drug resistance is often caused by mu...
Chronic myelogenous leukemia (CML) is the first cancer known to be associated with reciprocal transl...
Although the BCR-ABL hybrid gene on chromosome 22q-plays a pivotal role in the pathogenesis of chron...
Chronic Myeloid Leukaemia (CML) is a myeloproliferative disorder whose hallmark is represe...
<p>Mutation status of 36 chronic myeloid leukemia (CML) patients in chronic phase with primary and s...
BCR-ABL1 compound mutations can confer high-level resistance to imatinib and other ABL1 tyrosine kin...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
Chronic myeloid leukemia (CML) has been the first human malignancy to be associated, more than 50 ye...
Objective: Ph or rearrangement genetic material (Chromosome), BCR-ABL within Long-lasting Chronic My...
Purpose: Point mutations within the ABL kinase domain of the BCR-ABL gene have been associated with ...
A minority of chronic myeloid leukemia patients (CML) express a variety of atypical BCR-ABL1 fusion ...
The Philadelphia (Ph’) chromosome in chronic myelogenous leukemia (CML) results in fusion of the bcr...
Introduction: Since undetectable BCR-ABL mRNA transcription does not always indicate eradication of ...
PURPOSE: Point mutations within the ABL kinase domain of the BCR-ABL gene have been associated with ...
Copyright © 2004 by American Society of HematologyMutations within the BCR-ABL kinase domain in imat...
In imatinib-treated chronic myeloid leuke-mia (CML), secondary drug resistance is often caused by mu...
Chronic myelogenous leukemia (CML) is the first cancer known to be associated with reciprocal transl...
Although the BCR-ABL hybrid gene on chromosome 22q-plays a pivotal role in the pathogenesis of chron...
Chronic Myeloid Leukaemia (CML) is a myeloproliferative disorder whose hallmark is represe...
<p>Mutation status of 36 chronic myeloid leukemia (CML) patients in chronic phase with primary and s...
BCR-ABL1 compound mutations can confer high-level resistance to imatinib and other ABL1 tyrosine kin...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
Chronic myeloid leukemia (CML) has been the first human malignancy to be associated, more than 50 ye...
Objective: Ph or rearrangement genetic material (Chromosome), BCR-ABL within Long-lasting Chronic My...
Purpose: Point mutations within the ABL kinase domain of the BCR-ABL gene have been associated with ...
A minority of chronic myeloid leukemia patients (CML) express a variety of atypical BCR-ABL1 fusion ...
The Philadelphia (Ph’) chromosome in chronic myelogenous leukemia (CML) results in fusion of the bcr...
Introduction: Since undetectable BCR-ABL mRNA transcription does not always indicate eradication of ...
PURPOSE: Point mutations within the ABL kinase domain of the BCR-ABL gene have been associated with ...
Copyright © 2004 by American Society of HematologyMutations within the BCR-ABL kinase domain in imat...
In imatinib-treated chronic myeloid leuke-mia (CML), secondary drug resistance is often caused by mu...
Chronic myelogenous leukemia (CML) is the first cancer known to be associated with reciprocal transl...
DOI
Add to ORKG